North America’s Most Awarded Contract Drug Substance Manufacturer
24 Life Science Leader CMO awards from 2014-2017
Click and view our video series on How to Select a CMO.
COMPANY OVERVIEW
PCI is one of the most awarded cGMP Contract API manufacturing companies that offers you everything you need from initial process research to commercial API manufacturing. We have more than 20 years of experience in contract chemical manufacturing, which has enabled us to develop deep expertise in custom NCEs, controlled substances (Schedule II-V), generic APIs, and custom manufactured fine chemicals. PCI combines the responsiveness of a small company with the capacity and capabilities of a much larger one.
IN THE NEWS
February 24, 2020
Avoiding FDA Drug Rescissions: Sponsors Seek CDMOs With Strong Regulatory Track Records
February 10, 2020
How Well Do You Know Your CDMO’s Manufacturing Capacity?
December 13, 2019
The Surge in Chinese Biotech Requires Collaboration and Cooperation on a Global Level
January 25, 2019
Continuous Manufacturing is Gaining Steam, but Batch Processing Continues to be a Proven Alternative
February 17, 2020
How Seqens North America Sustains a 96% On-Time Delivery Rate
February 3, 2020
Things You Should Know About Phase 1 API Manufacturing
January 24, 2020
Shattering Five Myths about CDMOs
January 15, 2020
Seqens North America Identifies Trends Affecting the Generic Drugs Sector in 2020
January 13, 2020
Key Considerations When Manufacturing APIs for Injectables
January 6, 2020
Opportunities Created by the Growing Convergence of Food and Pharmaceuticals
UPCOMING EVENTS
Click on an event below to arrange a meeting with PCI
